Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antibodies, Neutralizing | 3 | 2015 | 120 | 0.620 |
Why?
|
| Antibodies, Viral | 3 | 2016 | 309 | 0.590 |
Why?
|
| Dengue | 1 | 2015 | 44 | 0.500 |
Why?
|
| Nucleic Acids | 1 | 2015 | 32 | 0.500 |
Why?
|
| Antibodies, Monoclonal | 3 | 2017 | 1412 | 0.360 |
Why?
|
| Vaccines, DNA | 2 | 2016 | 18 | 0.260 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 2 | 2013 | 4 | 0.230 |
Why?
|
| Lyme Disease | 1 | 2019 | 9 | 0.170 |
Why?
|
| Bacterial Vaccines | 1 | 2019 | 42 | 0.160 |
Why?
|
| Antigens, Surface | 1 | 2019 | 103 | 0.160 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2019 | 54 | 0.160 |
Why?
|
| Lipoproteins | 1 | 2019 | 136 | 0.160 |
Why?
|
| Neutralization Tests | 2 | 2015 | 80 | 0.160 |
Why?
|
| DNA, Bacterial | 1 | 2019 | 243 | 0.150 |
Why?
|
| Pneumonia, Bacterial | 1 | 2017 | 29 | 0.150 |
Why?
|
| Antibodies, Bispecific | 1 | 2017 | 26 | 0.150 |
Why?
|
| Plasmids | 2 | 2019 | 291 | 0.150 |
Why?
|
| Antibodies, Bacterial | 1 | 2017 | 100 | 0.140 |
Why?
|
| Protein Engineering | 1 | 2017 | 141 | 0.140 |
Why?
|
| Chikungunya Fever | 1 | 2016 | 2 | 0.140 |
Why?
|
| Viral Vaccines | 1 | 2016 | 44 | 0.130 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2017 | 202 | 0.130 |
Why?
|
| Chemoprevention | 1 | 2016 | 92 | 0.130 |
Why?
|
| Middle East Respiratory Syndrome Coronavirus | 1 | 2015 | 11 | 0.130 |
Why?
|
| K562 Cells | 1 | 2015 | 44 | 0.130 |
Why?
|
| Cross Reactions | 1 | 2015 | 109 | 0.130 |
Why?
|
| Immunoglobulin G | 1 | 2017 | 465 | 0.130 |
Why?
|
| Vero Cells | 1 | 2015 | 103 | 0.130 |
Why?
|
| Dengue Virus | 1 | 2015 | 43 | 0.130 |
Why?
|
| Viral Envelope Proteins | 1 | 2015 | 94 | 0.120 |
Why?
|
| Antigens, Viral | 1 | 2015 | 145 | 0.120 |
Why?
|
| Recombinant Proteins | 2 | 2013 | 1012 | 0.120 |
Why?
|
| AIDS Vaccines | 1 | 2013 | 10 | 0.120 |
Why?
|
| HIV Antibodies | 1 | 2013 | 26 | 0.110 |
Why?
|
| Cell Line | 2 | 2015 | 2496 | 0.110 |
Why?
|
| Mice | 6 | 2019 | 11761 | 0.110 |
Why?
|
| Immunity, Cellular | 1 | 2013 | 178 | 0.110 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2019 | 969 | 0.110 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2014 | 319 | 0.110 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2013 | 83 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 4 | 2017 | 1088 | 0.110 |
Why?
|
| Immunotherapy | 2 | 2015 | 682 | 0.110 |
Why?
|
| HIV-1 | 1 | 2013 | 166 | 0.100 |
Why?
|
| Receptor, ErbB-2 | 1 | 2014 | 246 | 0.100 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2014 | 394 | 0.100 |
Why?
|
| Animals | 8 | 2019 | 27369 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 3218 | 0.080 |
Why?
|
| Mice, SCID | 2 | 2019 | 261 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2019 | 640 | 0.070 |
Why?
|
| Electroporation | 2 | 2016 | 57 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 3011 | 0.040 |
Why?
|
| Ticks | 1 | 2019 | 2 | 0.040 |
Why?
|
| Borrelia burgdorferi | 1 | 2019 | 6 | 0.040 |
Why?
|
| Mice, Inbred C3H | 1 | 2019 | 371 | 0.040 |
Why?
|
| Transfection | 1 | 2019 | 911 | 0.040 |
Why?
|
| Pseudomonas Infections | 1 | 2017 | 99 | 0.040 |
Why?
|
| Humans | 5 | 2019 | 89349 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 2016 | 64 | 0.030 |
Why?
|
| Camelus | 1 | 2015 | 6 | 0.030 |
Why?
|
| Enzyme-Linked Immunospot Assay | 1 | 2013 | 8 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 195 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 2013 | 172 | 0.030 |
Why?
|
| Genetic Engineering | 1 | 2014 | 115 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 397 | 0.030 |
Why?
|
| Biological Therapy | 1 | 2013 | 47 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2014 | 308 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2014 | 215 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 374 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2015 | 466 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2013 | 691 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2014 | 449 | 0.020 |
Why?
|
| Cytokines | 1 | 2013 | 803 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 2366 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 2558 | 0.020 |
Why?
|
| Female | 3 | 2019 | 46200 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 5337 | 0.020 |
Why?
|
| HIV Infections | 1 | 2013 | 840 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 8241 | 0.010 |
Why?
|